WithdrawnNot Applicable

Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain

Stopped: Study not initiated prior to enrollment.

Spain0Started 2024-05-01

Plain-language summary

the goal of this clinical trial is to compare in cancer patients: Is ultrasound-guided percutaneous neuromodulation useful for Anterior Knee Pain relief in cancer patients? Participants will receive treatments of ultrasound-guided percutaneous neuromodulation and pharmacological treatment Researchers will compare ultrasound-guided percutaneous neuromodulation versus pharmacological treatment to see if Anterior Knee Pain is reduced

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: The proposed inclusion criteria for the study are as follows: * Age between 18 and 65. * Pain in the front of the knee. * Taking drug therapy for lower-extremity pain. * Diagnosis of painful pathology in the anterior aspect of the knee secondary oncologic. Exclusion Criteria: The exclusion criteria are: * Traumatic history * Have had any type of analgesic treatment in the last 4 weeks (clinical, physical or orthostatic) * No need for drug treatment within the last 30 days of study initiation.

What they're measuring

Numerical Pain Rating Scale (NPRS) Anterior Knee Pain changes

Timeframe: 12 weeks

Victorian Institute of Sport Assessment-Patella (VISA-P)

Timeframe: 12 weeks

The OKS (Oxford Knee Score) questionnaire for knee function.

Timeframe: 12 weeks

The Lower Limb Functional Index (LLFI).

Timeframe: 12 weeks

Borg's Rating Perceived Exertion (RPE) questionnaire for perceived fatigue.

Timeframe: 12 weeks

Pressure pain threshold

Timeframe: 12 weeks

Trial details

NCT IDNCT06240390

SponsorUniversidad Europea de Canarias

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-30

View on ClinicalTrials.gov More Pain Cancer trials

Plain-language summary

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Numerical Pain Rating Scale (NPRS) Anterior Knee Pain changes

Timeframe: 12 weeks

Victorian Institute of Sport Assessment-Patella (VISA-P)

Timeframe: 12 weeks

The OKS (Oxford Knee Score) questionnaire for knee function.

Timeframe: 12 weeks

The Lower Limb Functional Index (LLFI).

Timeframe: 12 weeks

Borg's Rating Perceived Exertion (RPE) questionnaire for perceived fatigue.

Timeframe: 12 weeks

Pressure pain threshold

Timeframe: 12 weeks